This CTD dossier owner and manufacturer, established in 2004, is a leader in research and development of prescription medications adhering to European quality standards. Focusing on affordability, they utilize around 80 active ingredients to produce drugs across four key therapy areas: cardiovascular, nervous system, diabetes, and dyslipidemia. Their R&D department, equipped with German technology and staffed by specialists, has successfully developed prolonged-release and micronized dosage forms.They primarily operate in Vietnam but also export to Cambodia, Indonesia, Singapore, and other regions.